# Lucid Group, Inc.: financial statements, quarterly

LCID · Nasdaq · CIK 1811210 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lcid.md) · [Financials](/companies/lcid/financials.md) · [Filings](/companies/lcid/filings.md) · [Insiders](/companies/lcid/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lcid/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [138](/filings/0001628280-24-046263.md) | [157 d](/filings/0001628280-26-011053.md) | [173](/filings/0001628280-25-022685.md) | [201](/filings/0001811210-25-000007.md) | [200](/filings/0001628280-25-049571.md) | [234 d](/filings/0001628280-26-011053.md) | [235](/filings/0001628280-26-030517.md) | [259](/filings/0001628280-26-052606.md) | [337](/filings/0001628280-25-049571.md) | [523 d](/filings/0001628280-26-011053.md) | [282](/filings/0001628280-26-030517.md) | [405](/filings/0001628280-26-052606.md) |
| Cost of revenue | $m | [470](/filings/0001628280-24-046263.md) | [410 d](/filings/0001628280-26-011053.md) | [405](/filings/0001628280-25-022685.md) | [470](/filings/0001811210-25-000007.md) | [413](/filings/0001628280-25-049571.md) | [443 d](/filings/0001628280-26-011053.md) | [464](/filings/0001628280-26-030517.md) | [532](/filings/0001628280-26-052606.md) | [670](/filings/0001628280-25-049571.md) | [945 d](/filings/0001628280-26-011053.md) | [594](/filings/0001628280-26-030517.md) | [832](/filings/0001628280-26-052606.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [231](/filings/0001628280-24-046263.md) | [243 d](/filings/0001628280-26-011053.md) | [285](/filings/0001628280-25-022685.md) | [287](/filings/0001811210-25-000007.md) | [324](/filings/0001628280-25-049571.md) | [280 d](/filings/0001628280-26-011053.md) | [251](/filings/0001628280-26-030517.md) | [274](/filings/0001628280-26-052606.md) | [325](/filings/0001628280-25-049571.md) | [361 d](/filings/0001628280-26-011053.md) | [336](/filings/0001628280-26-030517.md) | [321](/filings/0001628280-26-052606.md) |
| Selling, general and administrative | $m | [190](/filings/0001628280-24-046263.md) | [241 d](/filings/0001628280-26-011053.md) | [213](/filings/0001628280-25-022685.md) | [210](/filings/0001811210-25-000007.md) | [234](/filings/0001628280-25-049571.md) | [244 d](/filings/0001628280-26-011053.md) | [212](/filings/0001628280-26-030517.md) | [257](/filings/0001628280-26-052606.md) | [283](/filings/0001628280-25-049571.md) | [282 d](/filings/0001628280-26-011053.md) | [304](/filings/0001628280-26-030517.md) | [300](/filings/0001628280-26-052606.md) |
| Operating income | $m | [(753)](/filings/0001628280-24-046263.md) | [(737) d](/filings/0001628280-26-011053.md) | [(730)](/filings/0001628280-25-022685.md) | [(787)](/filings/0001811210-25-000007.md) | [(771)](/filings/0001628280-25-049571.md) | [(733) d](/filings/0001628280-26-011053.md) | [(692)](/filings/0001628280-26-030517.md) | [(803)](/filings/0001628280-26-052606.md) | [(942)](/filings/0001628280-25-049571.md) | [(1,065) d](/filings/0001628280-26-011053.md) | [(989)](/filings/0001628280-26-030517.md) | [(1,082)](/filings/0001628280-26-052606.md) |
| Interest expense | $m | [3.3](/filings/0001628280-23-037354.md) | [7.8 d](/filings/0001628280-24-007209.md) | [7.5](/filings/0001628280-24-020633.md) | [6.7](/filings/0001811210-25-000007.md) | [8.5](/filings/0001628280-25-049571.md) | [10.3 d](/filings/0001628280-26-011053.md) | [11.9](/filings/0001628280-26-030517.md) | [23.7](/filings/0001628280-26-052606.md) | [25.6](/filings/0001628280-25-049571.md) | [33.9 d](/filings/0001628280-26-011053.md) | [41.1](/filings/0001628280-26-030517.md) | [47.8](/filings/0001628280-26-052606.md) |
| Income tax | $m | [0.3](/filings/0001628280-24-046263.md) | [0.0 d](/filings/0001628280-26-011053.md) | [0.2](/filings/0001628280-25-022685.md) | [(0.1)](/filings/0001811210-25-000007.md) | [0.5](/filings/0001628280-25-049571.md) | [0.6 d](/filings/0001628280-26-011053.md) | [(1.4)](/filings/0001628280-26-030517.md) | [(2.4)](/filings/0001628280-26-052606.md) | [(0.4)](/filings/0001628280-25-049571.md) | [1.8 d](/filings/0001628280-26-011053.md) | [0.2](/filings/0001628280-26-030517.md) | [1.1](/filings/0001628280-26-052606.md) |
| Net income | $m | [(631)](/filings/0001628280-24-046263.md) | [(654) d](/filings/0001628280-26-011053.md) | [(681)](/filings/0001628280-25-022685.md) | [(643)](/filings/0001811210-25-000007.md) | [(992)](/filings/0001628280-25-049571.md) | [(397) d](/filings/0001628280-26-011053.md) | [(366)](/filings/0001628280-26-030517.md) | [(539)](/filings/0001628280-26-052606.md) | [(978)](/filings/0001628280-25-049571.md) | [(814) d](/filings/0001628280-26-011053.md) | [(1,028)](/filings/0001628280-26-030517.md) | [(1,035)](/filings/0001628280-26-052606.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001628280-24-046263.md) | not reported | [(0.30)](/filings/0001628280-25-022685.md) | [(0.34)](/filings/0001811210-25-000007.md) | [(4.09)](/filings/0001628280-25-049571.md) | not reported | [(2.41)](/filings/0001628280-26-030517.md) | [(2.80)](/filings/0001628280-26-052606.md) | [(3.31)](/filings/0001628280-25-049571.md) | not reported | [(3.46)](/filings/0001628280-26-030517.md) | [(3.30)](/filings/0001628280-26-052606.md) |
| Basic EPS | $ per share | [(0.28)](/filings/0001628280-24-046263.md) | not reported | [(0.30)](/filings/0001628280-25-022685.md) | [(0.34)](/filings/0001811210-25-000007.md) | [(4.09)](/filings/0001628280-25-049571.md) | not reported | [(2.41)](/filings/0001628280-26-030517.md) | [(2.42)](/filings/0001628280-26-052606.md) | [(3.31)](/filings/0001628280-25-049571.md) | not reported | [(3.46)](/filings/0001628280-26-030517.md) | [(3.30)](/filings/0001628280-26-052606.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,164](/filings/0001628280-23-037354.md) | [1,370](/filings/0001628280-25-007725.md) | [2,169](/filings/0001628280-24-020633.md) | [1,354](/filings/0001628280-24-034730.md) | [1,894](/filings/0001628280-24-046263.md) | [1,607](/filings/0001628280-26-011053.md) | [1,855](/filings/0001628280-25-022685.md) | [1,796](/filings/0001811210-25-000007.md) | [1,635](/filings/0001628280-25-049571.md) | [998](/filings/0001628280-26-052606.md) | [700](/filings/0001628280-26-030517.md) | [733](/filings/0001628280-26-052606.md) |
| Current assets | $m | [5,391](/filings/0001628280-23-037354.md) | [4,757](/filings/0001628280-25-007725.md) | [4,834](/filings/0001628280-24-020633.md) | [4,001](/filings/0001628280-24-034730.md) | [4,247](/filings/0001628280-24-046263.md) | [4,874](/filings/0001628280-26-011053.md) | [4,423](/filings/0001628280-25-022685.md) | [3,951](/filings/0001811210-25-000007.md) | [3,800](/filings/0001628280-25-049571.md) | [3,300](/filings/0001628280-26-052606.md) | [2,757](/filings/0001628280-26-030517.md) | [2,777](/filings/0001628280-26-052606.md) |
| Total assets | $m | [8,941](/filings/0001628280-23-037354.md) | [8,513](/filings/0001628280-25-007725.md) | [8,897](/filings/0001628280-24-020633.md) | [8,223](/filings/0001628280-24-034730.md) | [8,489](/filings/0001628280-24-046263.md) | [9,648](/filings/0001628280-26-011053.md) | [9,218](/filings/0001628280-25-022685.md) | [8,869](/filings/0001811210-25-000007.md) | [8,823](/filings/0001628280-25-049571.md) | [8,387](/filings/0001628280-26-052606.md) | [7,483](/filings/0001628280-26-030517.md) | [7,699](/filings/0001628280-26-052606.md) |
| Current liabilities | $m | [1,038](/filings/0001628280-23-037354.md) | [1,008](/filings/0001628280-25-007725.md) | [1,037](/filings/0001628280-24-020633.md) | [1,011](/filings/0001628280-24-034730.md) | [1,146](/filings/0001628280-24-046263.md) | [1,165](/filings/0001628280-26-011053.md) | [1,331](/filings/0001628280-25-022685.md) | [1,534](/filings/0001811210-25-000007.md) | [2,105](/filings/0001628280-25-049571.md) | [2,636](/filings/0001628280-26-052606.md) | [2,694](/filings/0001628280-26-030517.md) | [2,438](/filings/0001628280-26-052606.md) |
| Total liabilities | $m | [3,535](/filings/0001628280-23-037354.md) | [3,661](/filings/0001628280-25-007725.md) | [4,160](/filings/0001628280-24-020633.md) | [4,056](/filings/0001628280-24-034730.md) | [4,745](/filings/0001628280-24-046263.md) | [4,475](/filings/0001628280-26-011053.md) | [4,370](/filings/0001628280-25-022685.md) | [4,597](/filings/0001811210-25-000007.md) | [5,102](/filings/0001628280-25-049571.md) | [5,386](/filings/0001628280-26-052606.md) | [5,445](/filings/0001628280-26-030517.md) | [5,851](/filings/0001628280-26-052606.md) |
| Long-term debt | $m | [1,996](/filings/0001628280-23-037354.md) | [1,997](/filings/0001628280-25-007725.md) | [1,998](/filings/0001628280-24-020633.md) | [2,000](/filings/0001628280-24-034730.md) | [2,001](/filings/0001628280-24-046263.md) | [2,002](/filings/0001628280-26-011053.md) | [2,003](/filings/0001628280-25-022685.md) | [2,039](/filings/0001811210-25-000007.md) | [2,040](/filings/0001628280-25-049571.md) | [2,047](/filings/0001628280-26-052606.md) | [2,048](/filings/0001628280-26-030517.md) | [2,547](/filings/0001628280-26-052606.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [126](/filings/0001628280-26-011053.md) | not reported | not reported | not reported | [672](/filings/0001628280-26-052606.md) | [707](/filings/0001628280-26-030517.md) | [707](/filings/0001628280-26-052606.md) |
| Short-term borrowings | $m | [52.5](/filings/0001628280-23-037354.md) | [72.5](/filings/0001628280-25-007725.md) | [72.5](/filings/0001628280-24-020633.md) | [68.2](/filings/0001628280-24-034730.md) | [46.6](/filings/0001628280-24-046263.md) | [126](/filings/0001628280-25-049571.md) | [193](/filings/0001628280-25-022685.md) | [233](/filings/0001811210-25-000007.md) | [313](/filings/0001628280-25-049571.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [5,406](/filings/0001628280-24-046263.md) | [4,852](/filings/0001628280-26-011053.md) | [4,232](/filings/0001811210-25-000007.md) | [3,516](/filings/0001628280-25-049571.md) | [2,684](/filings/0001628280-25-049571.md) | [3,873](/filings/0001628280-26-052606.md) | [3,184](/filings/0001628280-26-052606.md) | [2,408](/filings/0001628280-26-052606.md) | [1,800](/filings/0001628280-25-049571.md) | [717](/filings/0001628280-26-052606.md) | [(351)](/filings/0001628280-26-052606.md) | [(1,058)](/filings/0001628280-26-052606.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(514) d](/filings/0001628280-24-046263.md) | [(475) d](/filings/0001628280-26-011053.md) | [(517)](/filings/0001628280-25-022685.md) | [(507) d](/filings/0001811210-25-000007.md) | [(463) d](/filings/0001628280-25-049571.md) | [(533) d](/filings/0001628280-26-011053.md) | [(429)](/filings/0001628280-26-030517.md) | [(830) d](/filings/0001628280-26-052606.md) | [(757) d](/filings/0001628280-25-049571.md) | [(916) d](/filings/0001628280-26-011053.md) | [(1,186)](/filings/0001628280-26-030517.md) | [(1,222) d](/filings/0001628280-26-052606.md) |
| Capital expenditure | $m | [193 d](/filings/0001628280-24-046263.md) | [273 d](/filings/0001628280-26-011053.md) | [198](/filings/0001628280-25-022685.md) | [234 d](/filings/0001811210-25-000007.md) | [160 d](/filings/0001628280-25-049571.md) | [292 d](/filings/0001628280-26-011053.md) | [161](/filings/0001628280-26-030517.md) | [183 d](/filings/0001628280-26-052606.md) | [199 d](/filings/0001628280-25-049571.md) | [325 d](/filings/0001628280-26-011053.md) | [253](/filings/0001628280-26-030517.md) | [254 d](/filings/0001628280-26-052606.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,691](/filings/0001628280-23-037354.md) | [1,832](/filings/0001628280-24-020633.md) | [1,912](/filings/0001628280-24-034730.md) | [2,284](/filings/0001628280-24-046263.md) | [2,302](/filings/0001628280-25-022685.md) | [2,310](/filings/0001811210-25-000007.md) | [232](/filings/0001628280-25-049571.md) | [304](/filings/0001628280-26-030517.md) | [306](/filings/0001628280-26-052606.md) | [312](/filings/0001628280-25-049571.md) | [328](/filings/0001628280-26-030517.md) | [382](/filings/0001628280-26-052606.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 394,070,176 at 2026-07-29, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052606.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.